BIO-TECHNE Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $499.0m $563.0m $643.0m $714.0m $738.7m $931.0m $1.1b $1.1b $1.2b $1.2b
Revenue from Contract with Customer, Including Assessed Tax $643.0m $714.0m $738.7m
Cost of Revenue $162.4m $188.5m $210.8m $240.5m $255.5m $298.2m $349.1m $366.9m $389.3m $429.4m
Gross Profit $336.7m $374.5m $432.1m $473.5m $483.2m $632.9m $756.5m $769.8m $769.7m $790.3m
Operating Expenses $186.1m $254.0m $296.0m $326.8m $325.8m $395.6m $459.9m $470.9m $563.0m $688.0m
Operating Income (Loss) $150.6m $120.6m $136.2m $146.7m $157.4m $237.3m $296.6m $298.9m $206.7m $102.3m
Additional Financial Items
Amortization of Intangible Assets $44.4m $47.1m $58.7m $61.1m $64.9m $74.1m $77.5m $79.9m $76.0m
Debt and Equity Securities, Realized Gain (Loss) $300k
Gain (Loss) on Investments $49.3m $283k
Gain (Loss) Related to Litigation Settlement ($3.5m)
Goodwill, Impairment Loss $0 $0 $0 $0 $0 ($825k) ($9.0m) $179k
Income (Loss) from Continuing Operations before Income Taxes, Domestic $120.2m $81.7m $81.6m $64.1m $245.4m $95.7m $255.1m $288.5m $174.8m $86.8m
Income (Loss) from Equity Method Investments ($1.1m) ($6.8m) $938k
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent ($13.5m) ($11.2m)
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic $108k $105k $224k $86k $121k $70k $33k $37k
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $147.5m $112.0m $126.0m $112.0m $276.5m $148.2m $301.4m $338.7m $185.7m $98.5m
Investment Income, Net $249k $304k $409k $569k $605k $473k $794k $3.4m $3.3m $3.9m
Net Income (Loss) Attributable to Parent $104.5m $76.1m $126.2m $96.1m $229.3m $140.4m $272.1m $285.3m $168.1m $73.4m
Net Income (Loss) Available to Common Stockholders, Basic $126.0m $96.0m $229.1m $140.3m $271.9m $285.2m $168.1m $73.4m
Net Income (Loss) Attributable to Noncontrolling Interest $0 $0 $0 $0 $0 ($825k) ($9.0m) $179k
Earnings Per Share, Basic $2.81 $2.04 $3.36 $2.54 $6.00 $3.62 $6.93 $1.81 $1.07 $0.47
Earnings Per Share, Diluted $2.80 $2.03 $3.31 $2.47 $5.82 $3.47 $6.63 $1.76 $1.05 $0.46
Common Stock, Dividends, Per Share, Declared $1.28 $1.28 $1.28 $1.28 $1.28 $1.28 $1.28 $0.32 $0.32 $0.32
Weighted Average Number of Shares Outstanding, Basic 37.2m 37.3m 37.5m 37.8m 38.2m 38.7m 39.2m 157.2m 157.7m 157.5m
Weighted Average Number of Shares Outstanding, Diluted 37.3m 37.5m 38.1m 38.9m 39.4m 40.5m 41.0m 161.9m 160.8m 159.7m
Selling, General and Administrative Expense $140.9m $200.4m $240.6m $264.4m $260.6m $325.0m $372.8m $378.4m $466.4m $588.5m
Other Nonoperating Income (Expense) ($1.6m) ($1.6m) ($447k) ($13.6m) $137.7m ($75.6m) $15.3m $47.5m ($8.6m) $831k
Interest Expense (non-operating) $15.7m $8.5m
Business Combination, Acquisition Related Costs ($19.1m) ($10.0m) $7.0m
Current Income Tax Expense (Benefit) $45.7m $30.0m $33.6m $36.6m $31.2m $83.0m $57.7m $76.2m
Interest Expense $1.7m $7.4m $10.2m $21.7m $19.2m $14.0m $11.3m $11.2m $15.7m $8.5m
Income Tax Expense (Benefit) $43.0m $35.9m ($198k) $15.9m $47.2m $8.6m $38.3m $53.2m $17.6m $25.1m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.